Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07407595
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18 to 65 years.
* No current pain at the time of inclusion and no pain episode or injury associated with pain within the past 3 months.
* Ability to understand spoken and written French sufficient to follow study procedures.
* Written informed consent obtained prior to participation.
* Subjects affiliated with or receiving social security benefits
Exclusion Criteria:
* History of psychiatric disorders (including intellectual disability or severe cognitive, behavioral, or affective impairment) that could interfere with understanding the study or providing informed consent.
* History of neurological disorders, including epilepsy, stroke, brain or spinal cord surgery, or any neurological disease affecting motor or sensory function.
Inability to provide informed consent (e.g., dementia, significant hearing impairment, insufficient language proficiency).
* Any pain condition within the past 3 months, regardless of origin.
* Recent musculoskeletal injury or surgery within the past 3 months.
* Contraindications to transcranial magnetic stimulation (TMS), including a history of epilepsy or the presence of intracranial metallic objects, cochlear implants, or other non-removable metallic implants in or near the head.
* Use of analgesic or psychotropic medications.
* Individuals under legal guardianship or curatorship.
* Pregnant or breastfeeding women.
* Presence of a cardiac pacemaker or other implanted electronic medical device.
* Known allergy or history of skin reaction to any component of the inert cream used in the study (Medicafarm® Neutre Premium Longue Glisse).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07407595
Study Brief:
Protocol Section:
NCT07407595